Eric Easom - 24 Oct 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Eric Easom
Issuer symbol
ANTX
Transactions as of
24 Oct 2022
Net transactions value
-$147,358
Form type
4
Filing time
26 Oct 2022, 21:19:30 UTC
Previous filing
24 Oct 2022
Next filing
28 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale $46,344 -2,866 -20% $16.17 11,391 24 Oct 2022 Direct F1
transaction ANTX Common Stock Sale $67,020 -4,272 -38% $15.69 7,119 25 Oct 2022 Direct F1
transaction ANTX Common Stock Sale $8,652 -534 -7.5% $16.20 6,585 25 Oct 2022 Direct F1
transaction ANTX Common Stock Sale $25,342 -1,678 -25% $15.10 4,907 26 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.